lundi 5 février 2018

Onco Actu du 5 février 2017

2.4 Etiologie - Portables, ondes e-m

Rodents and Radiation: What to Take Away from New Study Findings [ACS]

High exposure to radiofrequency radiation linked to tumor activity in male rats [NIH]

Of Science, Certainty, and the Safety of Cell Phone Radiation [Undark]

High doses of cellphone radiation linked to some cancers in rats [STAT]

New cell phone and health studies don't eliminate uncertainty [Science]

High levels of cellphone radiation linked to tumors in male rats: U.S. study [Reuters]

Statement from Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health on the recent National Toxicology Program draft report on radiofrequency energy exposure [FDA]

Radiation from cellphones is not hazardous to your health, government scientists say [LA Times]

Cellphones Are Still Safe for Humans, Researchers Say [NY Times]

Cellphone radiation study finds mixed effects in rodents, without clear implications for human health [Washington Post]

3.1 Prévention - Tabac

Senators traded in tobacco stocks while sitting on health committee [STAT]

4. Dépistage, diagnostic et pronostic

A prescription for cancer diagnostics [Nature Medicine]

4.2 Dép., diag. & prono. - Génome

Cracks in the code: Why mapping your DNA may be less reliable than you think [Globe and Mail]

4.7 Dép., diag. & prono. - Col de l'utérus

Women called back in after review of cervical cancer screening lab [The Guardian]

5.10 Traitements - Essais

A New Look at Clinical Success Rates [In the Pipeline]

5.12.10 Immunothérapies - Fusions et acquisitions

Buyout buzz hits fever pitch on report that Nektar is ‘exploring options’ [EndPoints]

5.12.2 Immunothérapies - CAR-T

Global landscape of CAR cell therapeutic companies [Cell Trials]

5.12.5 Immunothérapies - Pharma

AstraZeneca stops monotherapy study at centerpiece of $500M buyout [FierceBiotech]

5.12.8 Immunothérapies - Economie

Pharma Investors Suffer From Tax Myopia [Blomberg]

5.3 Traitements - FDA, EMA, NICE...

Evaluation of advanced therapy medicines [EMA]

5.4 Traitements - Economie

Faslodex rejected by NICE for NHS breast cancer use [Pharmafile]

Breast cancer drug approved for NHS in England [Cancer Research UK]

6.1 Observation

Breast cancer death rate down 10% in just five years [Cancer Research UK]

So men are dying because they don’t have women’s brains? Show me the evidence [The Guardian]

6.11 Patients

'I had a cough - in a few days I'm told it is cancer and without treatment, I will be dead in three months' [The Telegraph]

‘Cancer I could deal with. Losing my breast I could not’ [The Guardian]

6.8 Communication

Facebook boss Nicola Mendelsohn reveals she has incurable cancer [The Telegraph]